SLN:NASDAQ
Silence Therapeutics PLC - ADR
$14.65
arrow_downward
-0.95%(-0.14) 1D
Sep 4, 1:07:53 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLN...
Open
$14.63
High
$14.79
Low
$14.42
Mkt. cap
882.07M
Avg. vol.
1.50M
Volume
166.64K
52-wk high
$17.58
52-wk low
$4.19
EPS
-$1.45
Beta
1.45
Shares outstanding
60.21M
No. of employees
88
Open
$14.63
High
$14.79
Low
$14.42
Mkt. cap
882.07M
Avg. vol.
1.50M
Volume
166.64K
52-wk high
$17.58
52-wk low
$4.19
EPS
-$1.45
Beta
1.45
Shares outstanding
60.21M
No. of employees
88
Profile
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
About Silence Therapeutics PLC - ADR
CEOCraig A Tooman
Employees88
Founded1994
Headquarters-
SectorBiotechnology
Websitesilence-therapeutics.com